Desi sickle cell anaemia drug to price lower than 1% of imported variations | India Information
NEW DELHI: Hydroxyurea, a drugs used for treating sickle cell anaemia sufferers, will now be accessible in India for Rs 600 per vial — lower than 1% of the worth of its imported variations.Not like the variations bought by world manufacturers for round Rs 77,000 per vial, which want a storage temperature of 2-8 levels […]